Literature DB >> 15156572

Analysis of the adaptor function of the LIM domain-containing protein FHL2 using an affinity chromatography approach.

Haquima El Mourabit1, Stefan Müller, Lucy Tunggal, Mats Paulsson, Monique Aumailley.   

Abstract

Containing four LIM domains and an N-terminal half LIM domain, FHL2 has been predicted to have an adaptor function in the formation of higher order molecular complexes in the nucleus and the cytoplasm of cells. We expressed recombinant FHL2 in insect cells using the baculovirus system and used it to isolate direct or indirect interaction partners from the cytosolic fraction of fibroblasts by affinity chromatography. These were identified by their peptide mass fingerprints using MALDI-TOF mass spectrometry. Cytoskeleton-associated proteins present among the bound proteins were shown to co-localise with FHL2 in cell lamellipodia by indirect immunofluorescence staining. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15156572     DOI: 10.1002/jcb.20096

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.

Authors:  Christina K Matulis; Kelly E Mayo
Journal:  Mol Endocrinol       Date:  2012-06-25

2.  LIM-only protein FHL2 is a positive regulator of liver X receptors in smooth muscle cells involved in lipid homeostasis.

Authors:  Kondababu Kurakula; Daniela Sommer; Milka Sokolovic; Perry D Moerland; Saskia Scheij; Pieter B van Loenen; Duco S Koenis; Noam Zelcer; Claudia M van Tiel; Carlie J M de Vries
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

3.  Effects of constitutively active GTPases on fibroblast behavior.

Authors:  Z-G Zhang; C A Lambert; S Servotte; G Chometon; B Eckes; T Krieg; C M Lapière; B V Nusgens; M Aumailley
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.